Balance Sheet Medpace Holdings, Inc.

Equities

MEDP

US58506Q1094

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2024-09-13 EDT			5-day change	1st Jan Change
351.67 ^USD	+1.95%		+4.74%	+14.73%

08-26	Medpace Holdings Insider Sold Shares Worth $3,175,463, According to a Recent SEC Filing	MT
08-15	Skanska Builds New Office Building in Cincinnati, Ohio, USA, for USD 164 Million, About SEK 1.7 Billion	CI

60827761c193c81cb6719316.t72NPztK8dHDD2qQqokqoz05B5DA6nyyin5HRjVkYCY.9Yv4bXMHgrKSTTvg8O5H_ApzMtutuRLG_QQMKE8HB2ToxL4MbyykopR3Wg

Published financial data: MEDPACE HOLDINGS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	861M	926M	1.14B	1.46B	1.89B
Total Revenues	861M	926M	1.14B	1.46B	1.89B
Cost of Goods Sold, Total	321M	354M	441M	535M	638M
Gross Profit	540M	571M	701M	925M	1.25B
Selling General & Admin Expenses, Total	95.24M	92.16M	108M	131M	161M
Depreciation & Amortization - (IS)	8.36M	11.65M	16M	18.99M	24.13M
Amortization of Goodwill and Intangible Assets - (IS)	14.83M	7.88M	5.11M	3.35M	2.2M
Other Operating Expenses	294M	293M	373M	493M	723M
Other Operating Expenses, Total	413M	404M	503M	646M	911M
Operating Income	127M	167M	199M	279M	337M
Interest Expense, Total	-1.57M	-	-105K	-2.9M	-488K
Interest And Investment Income	-	307K	-	-	-
Net Interest Expenses	-1.57M	307K	-105K	-2.9M	-488K
Currency Exchange Gains (Loss)	-581K	514K	2.78M	3.86M	-1.93M
Other Non Operating Income (Expenses)	-282K	669K	563K	3.21M	1.27M
EBT, Excl. Unusual Items	125M	169M	202M	283M	336M
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	125M	169M	202M	283M	336M
Income Tax Expense	24.39M	23.15M	20M	37.49M	52.87M
Earnings From Continuing Operations	100M	145M	182M	245M	283M
Net Income to Company	100M	145M	182M	245M	283M
Net Income - (IS)	100M	145M	182M	245M	283M
Preferred Dividend and Other Adjustments	279K	459K	458K	157K	191K
Net Income to Common Incl Extra Items	100M	145M	181M	245M	283M
Net Income to Common Excl. Extra Items	100M	145M	181M	245M	283M
Per Share Items
Net EPS - Basic	2.79	4.07	5.06	7.57	9.2
Basic EPS - Continuing Operations	2.79	4.07	5.06	7.57	9.2
Basic Weighted Average Shares Outstanding	35.88M	35.64M	35.86M	32.39M	30.72M
Net EPS - Diluted	2.67	3.84	4.81	7.28	8.88
Diluted EPS - Continuing Operations	2.67	3.84	4.81	7.28	8.88
Diluted Weighted Average Shares Outstanding	37.58M	37.71M	37.7M	33.67M	31.84M
Normalized Basic EPS	2.17	2.96	3.52	5.46	6.83
Normalized Diluted EPS	2.08	2.79	3.35	5.25	6.59
Supplemental Items
EBITDA	150M	187M	220M	301M	363M
EBITA	142M	175M	204M	282M	339M
EBIT	127M	167M	199M	279M	337M
EBITDAR	166M	212M	250M	335M	401M
Total Revenues (As Reported)	861M	-	-	-	-
Effective Tax Rate - (Ratio)	19.54	13.74	9.91	13.25	15.75
Current Domestic Taxes	12.34M	20.99M	54.54M	57.15M	73.23M
Current Foreign Taxes	2.02M	1.59M	2.58M	3.33M	4.62M
Total Current Taxes	14.36M	22.58M	57.12M	60.48M	77.85M
Deferred Domestic Taxes	9.91M	531K	-36.3M	-23M	-25.99M
Deferred Foreign Taxes	119K	38K	-820K	13K	1.01M
Total Deferred Taxes	10.03M	569K	-37.12M	-22.99M	-24.98M
Normalized Net Income	78.02M	105M	126M	177M	210M
Supplemental Operating Expense Items
Advertising Expense	700K	700K	1.2M	1.3M	1.5M
Selling and Marketing Expenses	700K	700K	1.2M	1.3M	1.5M
Net Rental Expense, Total	15.96M	25.18M	30.5M	34.44M	37.37M
Imputed Operating Lease Interest Expense	2.46M	-	184K	4.5M	783K
Imputed Operating Lease Depreciation	13.5M	-	30.32M	29.94M	36.59M
Stock-Based Comp., COGS (Total)	7M	7.78M	9.34M	11.8M	11.1M
Stock-Based Comp., SG&A Exp. (Total)	13.74M	6M	5.12M	9.61M	9.42M
Total Stock-Based Compensation	20.74M	13.78M	14.47M	21.41M	20.52M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	132M	278M	461M	28.26M	245M
Total Cash And Short Term Investments	132M	278M	461M	28.26M	245M
Accounts Receivable, Total	156M	161M	186M	253M	298M
Other Receivables	-	-	-	11.3M	12.2M
Notes Receivable	-	-	-	-	300K
Total Receivables	156M	161M	186M	265M	311M
Prepaid Expenses	29.45M	34.92M	43.18M	40.99M	37.48M
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	317M	474M	691M	334M	594M
Gross Property Plant And Equipment	131M	238M	274M	311M	345M
Accumulated Depreciation	-31.63M	-39.11M	-51.1M	-62.12M	-79.4M
Net Property Plant And Equipment	99.44M	199M	223M	249M	265M
Goodwill	662M	662M	662M	662M	662M
Other Intangibles, Total	54.35M	46.47M	41.36M	38.01M	35.81M
Deferred Tax Assets Long-Term	376K	536K	25.13M	48.08M	74.44M
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	9.48M	8.79M	17.42M	21.13M	24.97M
Total Assets	1.14B	1.39B	1.66B	1.35B	1.66B
Liabilities
Accounts Payable, Total	22.4M	26.55M	25.68M	33.07M	31.87M
Accrued Expenses, Total	109M	134M	159M	223M	293M
Short-term Borrowings	-	-	-	50M	-
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	10.98M	15.89M	16.28M	19.27M	22.36M
Unearned Revenue Current, Total	192M	256M	345M	463M	560M
Other Current Liabilities	8.01M	7.64M	11.34M	15.78M	18.08M
Total Current Liabilities	343M	440M	557M	803M	925M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	45.21M	115M	131M	139M	142M
Deferred Tax Liability Non Current	12.85M	13.55M	1.08M	1.07M	2.4M
Other Non Current Liabilities	15.72M	16.09M	17.74M	22.7M	28.22M
Total Liabilities	417M	585M	707M	966M	1.1B
Common Stock, Total	360K	355K	360K	309K	308K
Additional Paid In Capital	667M	696M	728M	771M	803M
Retained Earnings	68.11M	115M	235M	-360M	-222M
Treasury Stock	-6.03M	-5.58M	-5.43M	-12.5M	-12.32M
Comprehensive Income and Other	-2.74M	-131K	-4.85M	-12.39M	-10.07M
Total Common Equity	726M	806M	953M	386M	559M
Total Equity	726M	806M	953M	386M	559M
Total Liabilities And Equity	1.14B	1.39B	1.66B	1.35B	1.66B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	36.09M	35.73M	35.23M	31.05M	30.69M
ECS Total Common Shares Outstanding	35.87M	35.33M	35.83M	31.02M	30.68M
Book Value / Share	20.25	22.8	26.6	12.46	18.22
Tangible Book Value	9.54M	96.91M	249M	-314M	-139M
Tangible Book Value Per Share	0.27	2.74	6.95	-10.12	-4.54
Total Debt	56.19M	131M	147M	208M	164M
Net Debt	-75.73M	-147M	-314M	180M	-80.96M
Debt Equivalent Oper. Leases	128M	201M	244M	276M	299M
Account Code - Inventory Valuation	5	5	5	5	5
Land - (BS)	1.58M	2.49M	2.45M	2.41M	4.83M
Buildings, Total	13.27M	14.31M	13.77M	13.59M	16.42M
Machinery, Total	60.81M	103M	118M	145M	172M
Full Time Employees	3.5K	3.6K	4.5K	5.2K	5.9K
Accumulated Allowance for Doubtful Accounts (Supple)	583K	346K	171K	170K	7K
Order Backlog	1.28B	1.54B	2B	2.34B	2.81B

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	100M	145M	182M	245M	283M
Depreciation & Amortization - CF	8.36M	11.65M	16M	18.99M	24.13M
Amortization of Goodwill and Intangible Assets - (CF)	14.83M	7.88M	5.11M	3.35M	2.2M
Depreciation & Amortization, Total	23.19M	19.53M	21.12M	22.34M	26.33M
Amortization of Deferred Charges, Total - (CF)	954K	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	-
Stock-Based Compensation (CF)	20.74M	13.78M	14.47M	21.41M	20.52M
Other Operating Activities, Total	20.95M	13.72M	-20.82M	-7.13M	-2.77M
Change In Accounts Receivable	-21.26M	-5.53M	-24.98M	-66.92M	-48.28M
Change In Accounts Payable	4.73M	-2.6M	1.87M	6.43M	1.05M
Change in Unearned Revenues	44.58M	63.41M	88.98M	118M	97.13M
Change in Other Net Operating Assets	7.53M	10.98M	846K	48.46M	56.59M
Cash from Operations	202M	259M	263M	388M	433M
Capital Expenditure	-17.91M	-31.34M	-28.27M	-36.88M	-36.65M
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-
Other Investing Activities, Total	-1.23M	126K	-3.09M	-1.86M	2.02M
Cash from Investing	-19.14M	-31.21M	-31.36M	-38.74M	-34.63M
Short Term Debt Issued, Total	-	-	-	324M	105M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	324M	105M
Short Term Debt Repaid, Total	-	-	-	-274M	-155M
Long-Term Debt Repaid, Total	-80.44M	-	-	-	-
Total Debt Repaid	-80.44M	-	-	-274M	-155M
Issuance of Common Stock	6.52M	15.99M	17.64M	22.07M	11.38M
Repurchase of Common Stock	-	-98.27M	-62.1M	-848M	-144M
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	-73.92M	-82.28M	-44.45M	-776M	-183M
Foreign Exchange Rate Adjustments	-167K	666K	-3.97M	-6.57M	1.08M
Net Change in Cash	109M	146M	184M	-433M	217M
Supplemental Items
Cash Interest Paid	1.49M	104K	123K	2.94M	3.06M
Cash Income Tax Paid (Refund)	13.24M	23.1M	56.24M	50.16M	76.35M
Levered Free Cash Flow	152M	188M	214M	296M	346M
Unlevered Free Cash Flow	152M	188M	214M	298M	347M
Change In Net Working Capital	-46.83M	-81.42M	-83M	-117M	-126M
Net Debt Issued / Repaid	-80.44M	-	-	50M	-50M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	7.54	8.24	8.14	11.56	13.99
Return on Total Capital	10.76	12.14	12.19	20.56	31.95
Return On Equity %	15.26	18.98	20.68	36.64	59.83
Return on Common Equity	15.22	18.92	20.63	36.62	59.79
Margin Analysis
Gross Profit Margin %	62.72	61.72	61.39	63.36	66.16
SG&A Margin	11.06	9.95	9.49	9	8.56
EBITDA Margin %	17.47	20.15	19.23	20.62	19.26
EBITA Margin %	16.5	18.89	17.83	19.32	17.98
EBIT Margin %	14.78	18.04	17.39	19.09	17.86
Income From Continuing Operations Margin %	11.67	15.7	15.92	16.81	15
Net Income Margin %	11.67	15.7	15.92	16.81	15
Net Avail. For Common Margin %	11.63	15.65	15.88	16.8	14.99
Normalized Net Income Margin	9.06	11.38	11.04	12.11	11.12
Levered Free Cash Flow Margin	17.7	20.28	18.77	20.3	18.36
Unlevered Free Cash Flow Margin	17.7	20.28	18.77	20.43	18.38
Asset Turnover
Asset Turnover	0.82	0.73	0.75	0.97	1.25
Fixed Assets Turnover	11.35	6.21	5.42	6.19	7.33
Receivables Turnover (Average Receivables)	5.96	5.85	6.58	6.64	6.84
Short Term Liquidity
Current Ratio	0.92	1.08	1.24	0.42	0.64
Quick Ratio	0.84	1	1.16	0.36	0.6
Operating Cash Flow to Current Liabilities	0.59	0.59	0.47	0.48	0.47
Days Sales Outstanding (Average Receivables)	61.28	62.58	55.5	54.98	53.4
Average Days Payable Outstanding	22.25	25.28	21.61	20.04	18.57
Long Term Solvency
Total Debt/Equity	7.74	16.26	15.45	53.87	29.43
Total Debt / Total Capital	7.18	13.99	13.38	35.01	22.74
LT Debt/Equity	6.23	14.29	13.74	35.94	25.43
Long-Term Debt / Total Capital	5.78	12.29	11.9	23.36	19.65
Total Liabilities / Total Assets	36.46	42.06	42.59	71.43	66.26
EBIT / Interest Expense	81.16	-	1.89K	95.94	690.22
EBITDA / Interest Expense	106.13	-	2.38K	115.48	820.75
(EBITDA - Capex) / Interest Expense	94.71	-	2.11K	102.79	745.65
Total Debt / EBITDA	0.34	0.62	0.59	0.62	0.41
Net Debt / EBITDA	-0.46	-0.69	-1.26	0.54	-0.2
Total Debt / (EBITDA - Capex)